Circulating tumor DNA reveals mechanisms of lorlatinib resistance in patients with relapsed/refractory ALK-driven neuroblastoma
循环肿瘤 DNA 揭示复发/难治性 ALK 驱动神经母细胞瘤患者对劳拉替尼产生耐药性的机制
期刊:Nature Communications
影响因子:14.7
doi:10.1038/s41467-023-38195-0
Esther R Berko #, Gabriela M Witek #, Smita Matkar #, Zaritza O Petrova #, Megan A Wu, Courtney M Smith, Alex Daniels, Joshua Kalna, Annie Kennedy, Ivan Gostuski, Colleen Casey, Kateryna Krytska, Mark Gerelus, Dean Pavlick, Susan Ghazarian, Julie R Park, Araz Marachelian, John M Maris, Kelly C Golds